Boston Scientific Gains J&J Device Chief As President, Then CEO

Boston Scientific will have three successive CEOs over the next 14 months in a transition process that will end with the current device and diagnostics business chief for long-time rival Johnson & Johnson taking the helm.

More from Archive

More from Medtech Insight